1. TAVR and the Risk of Thrombosis

2. Program Goals

3. Thromboembolic Risk Associated With TAVR

4. Timing of Stroke and Bleeding Post TAVR

5. Stroke After TAVR -- Pathophysiology

6. TAVR and AF Background

7. Leaflet Thrombosis in Bioprosthetic Aortic Valves: Clinical Outcomes

8. Current Indications for Antithrombotic Therapy After TAVR

9. DAPT vs SAPT in TAVR

10. ENVISAGE TAVI AF -- Study Design

11. NOAC SPAF Trials Meta-Analysis of 71,683 Patients

12. GALILEO: Study Design

13. Unanswered Questions in TAVR and the Potential Role for NOACs

14. Abbreviations

15. Abbreviations (cont)